Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:58:24.809Z.
Calculation as of: 2026-10-06T18:58:24.809Z.
Quote observation: 2026-10-06T18:54:31.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e64ee45e162b8fcb3c04564696a4f5631675aa9d571ebc51c9b2157b48bafcf8
EARNINGS YIELD
N/A
Rani Therapeutics Holdings, Inc.
Market Cap
$54.02M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.55M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$53.02M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.46M
Earnings Yield
N/A
TTM Avg
64.71%
3Y Avg
64.71%
5Y Avg
64.71%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | $54.02M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | N/A | N/A | N/A | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $53.55M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $53.52M | N/A | 64.30% | 64.30% | 64.30% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.02M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $52.04M | 9.89% | 27.99% | 16.26% | 33.61% |
| OKYO Pharma Limited (OKYO)vs › | $56.40M | N/A | N/A | N/A | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.46M | N/A | 64.71% | 64.71% | 64.71% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
